Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Below the window, the drug does not work
Retatrutide dosing in trials follows a step-up approach, with increases every 4 weeks, similar to GLP-1 medications, to help your body adjust to side effects
Always consult a qualified healthcare provider regarding medical concerns or treatment decisions.
Always store pens in their original packaging with clear labeling until use
*** The information provided on this website is for informational purposes only and should not be construed as medical advice
Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant
US$ 24.18
US$ 22.40
US$ 22.76
US$ 25.03
US$ 25.84
US$ 21.23
US$ 25.71
US$ 20.77
US$ 23.69
